Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Thyroidectomy
Interventions
DRUG

bilateral superficial cervical block

10 ml of 5% bupivacaine (Carbostesin®) was used for each side. Along the cranial dorsal edge of the sternocleidomastoid muscle, three deposits of approximately 2.5 ml were injected to anaesthetize the cervical plexus with its nervus transversus colli. To anaesthetize the region of the planned skin incision, the remaining 2·5 ml was injected subcutaneously on each side.

DRUG

placebo bilateral superficial cervical block

"10 ml of saline (the carrier of bupivacaine in the experimental treatment) was used for each side.~Along the cranial dorsal edge of the sternocleidomastoid muscle, three deposits of approximately 2.5 ml were injected to anaesthetize the cervical plexus with its nervus transversus colli. To anaesthetize the region of the planned skin incision, the remaining 2·5 ml was injected subcutaneously on each side."

Trial Locations (1)

9007

Department of Surgery, Cantonal Hospital of St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Cantonal Hospital of St. Gallen

OTHER

NCT00472446 - Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter